Literature DB >> 12172082

Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy.

Cristina Mussini1, Marcello Pinti, Vanni Borghi, Milena Nasi, Grazia Amorico, Elena Monterastelli, Laura Moretti, Leonarda Troiano, Roberto Esposito, Andrea Cossarizza.   

Abstract

OBJECTIVE: To identify crucial immunological characteristics of a group of patients, defined 'CD4-exploders', who were able to fully reconstitute their immune system after receiving highly active antiretroviral therapy (HAART). PATIENTS: Among a population of 540 HIV-positive patients treated with HAART, six individuals were identified who experienced a nadir of less than 85 x 106 CD4+ cells/l, had major opportunistic infections (four out of six), started HAART in 1996 or 1997, and showed a rapid and relevant CD4+ lymphocyte increase (mainly due to virgin cells), in some cases regardless of virological control.
METHODS: Enzyme-linked immunosorbent assay for the determination of interleukin (IL)-7 plasma levels; flow cytometry to analyse surface antigens and CD127 (IL-7 receptor alpha-chain) expression; quantitative-competitive (QC) PCR for detecting cells containing T-cell receptor rearrangement excision circles (TREC); chest-computed tomography (CT) to analyse thymus volume and content.
RESULTS: In 'CD4-exploders', high levels of TREC+ lymphocytes were found among CD4+ T cells, which also contained a high percentage of naive cells. However, CT revealed a dramatic depletion of intrathymic lymphoid tissue. Plasma levels of IL-7 were significantly high. Most CD4+ and CD8+ T lymphocytes expressed CD127, whose level was similar to that of healthy donors. CD127 expression on CD8+ lymphocytes was markedly higher than in HIV-positive individuals treated with the same therapy or in patients with AIDS.
CONCLUSION: In 'CD4-exploders', HAART-induced reconstitution of the T-cell compartment is independent from thymus volume, and is favoured by the upregulation of the IL-7/IL-7 receptor system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172082     DOI: 10.1097/00002030-200208160-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

3.  Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.

Authors:  Jessica N Hodge; Sharat Srinivasula; Zonghui Hu; Sarah W Read; Brian O Porter; Insook Kim; Joann M Mican; Chang Paik; Paula Degrange; Michele Di Mascio; Irini Sereti
Journal:  Blood       Date:  2011-07-21       Impact factor: 22.113

Review 4.  Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.

Authors:  Martyn A French
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

5.  CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).

Authors:  J-H Colle; J-L Moreau; A Fontanet; O Lambotte; M Joussemet; J-F Delfraissy; J Thèze
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 6.  [Immune restoration inflammatory syndromes].

Authors:  M Stoll; H Heiken; G M N Behrens; R E Schmidt
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

7.  Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

Authors:  Matthias Stoll; Reinhold E. Schmidt
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

8.  Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs.

Authors:  L Kolte; J C Gaardbo; K Skogstrand; L P Ryder; A K Ersbøll; S D Nielsen
Journal:  Clin Exp Immunol       Date:  2008-11-06       Impact factor: 4.330

9.  Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection.

Authors:  Sarah C Sasson; John J Zaunders; Nabila Seddiki; Michelle Bailey; Kristin McBride; Kersten K Koelsch; Kate M Merlin; Don E Smith; David A Cooper; Anthony D Kelleher
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

10.  Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.

Authors:  Katalin A Wilkinson; Ronnett Seldon; Graeme Meintjes; Molebogeng X Rangaka; Willem A Hanekom; Gary Maartens; Robert J Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2009-07-23       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.